Beta cell replacement through transplantation remains the only treatment option for Type 1 diabetes enabling restoration of near-physiological glucose levels without significant hypoglycemia. Outlining the most recent advances and research breakthroughs, this practical guide and reference work explores the impact of islet cell transplantation and brings together leading multidisciplinary proponents critical to future success in the field. Edited by a surgeon and an endocrinologist at the forefront of the technology, this volume considers challenges associated with this procedure including lack of sufficient donor organs and the side effects of immunosuppressive therapy, as well as the potential benefits for current and future patients.

A. M. JAMES SHAPIRO is Professor of Surgery, Division of General Surgery, University of Alberta, Canada, and Director of Clinical Islet Transplant Program, Staff Surgeon, and Director of the Juvenile Diabetes Foundation Clinical Center for Islet Transplantation, University of Alberta Hospital, Canada. Dr. Shapiro received his M.B.B.S. from the University of Newcastle on Tyne, England, and his Ph.D. in Experimental Surgery, University of Alberta. Dr. Shapiro currently investigates islet transplantation for the treatment of type 1 diabetes and the immunobiology and tolerance induction for islet cell transplantation, and currently has written over 150 peer reviewed articles and over 15 books and chapters in the field of diabetes.

JAMES A. M. SHAW is a Senior Lecturer in Diabetes at the University of Newcastle within the Institute of Cellular Medicine, Institute of Cell and Molecular Biosciences and the North East Stem Cell Institute. He is a consultant physician in the Newcastle upon Tyne Acute Hospitals Foundation Trust and the Newcastle Primary Care Trust. Dr Shaw received his BSc from St Andrews University, Scotland; MB ChB from the University of Manchester, England; and PhD from the University of Aberdeen, Scotland. He held a Medical Research Council Training Fellowship and GlaxoSmithKline Senior Fellowship. He is a Fellow of the Royal College of Physicians of Edinburgh. In addition to his clinical interests in insulin pump therapy, pancreas and islet transplantation, his research group are exploring gene therapy for diabetes and beta cell replacement including stem cell approaches.

A Historical Perspective on Experimental and Clinical Islet Transplantation. Hypoglycemia in Type 1 Diabetes: The Need for a New Approach. Patient Selection and Assessment: An Endocrinologist's Perspective. The Surgical Aspects of Pancreas Procurement for Pancreatic Islet Transplantation. Pancreas Preservation for Islet Isolation. Aspects and Challenges of Islet Isolation. Percutaneous Portal Vein Access: Radiological Aspects. Care of the Islet Transplant Recipient - Immunosuppressive Management and Complications. Islet Graft Monitoring and Imaging. Metabolic Measures of Islet Function and Mass After Islet Transplantation. Challenges in Setting Up a New Islet Transplant Program. Key Factors to Consider in Setting Up Clinical Trials in Islet Cell Transplantation: A Nursing Coordinator's Perspective. Clinical Outcomes and Future Directions in Islet Transplantation. Culture and Transportation of Human Islets Between Centers. Development and Application of Contemporary Immunosuppresion in Human Islet Transplantation. Pig Islet Xenotransplantation-Update and Context. Approaches to cell Regeneration and Neogenesis. Stem Cell Approaches for cell Replacement. Diabetes Gene Therapy